GRAIL (GRAL) Competitors $32.37 -0.05 (-0.15%) As of 09:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GRAL vs. SHC, OPCH, BTSG, NAKA, WGS, CON, SGRY, PRVA, VCYT, and HTFLShould you be buying GRAIL stock or one of its competitors? The main competitors of GRAIL include Sotera Health (SHC), Option Care Health (OPCH), BrightSpring Health Services (BTSG), KindlyMD (NAKA), GeneDx (WGS), Concentra Group Holdings Parent (CON), Surgery Partners (SGRY), Privia Health Group (PRVA), Veracyte (VCYT), and Heartflow (HTFL). These companies are all part of the "healthcare" industry. GRAIL vs. Its Competitors Sotera Health Option Care Health BrightSpring Health Services KindlyMD GeneDx Concentra Group Holdings Parent Surgery Partners Privia Health Group Veracyte Heartflow Sotera Health (NASDAQ:SHC) and GRAIL (NASDAQ:GRAL) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk, media sentiment and valuation. Is SHC or GRAL more profitable? Sotera Health has a net margin of 2.14% compared to GRAIL's net margin of -329.86%. Sotera Health's return on equity of 39.42% beat GRAIL's return on equity.Company Net Margins Return on Equity Return on Assets Sotera Health2.14% 39.42% 5.66% GRAIL -329.86%-16.64%-14.02% Which has preferable valuation & earnings, SHC or GRAL? Sotera Health has higher revenue and earnings than GRAIL. GRAIL is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSotera Health$1.12B3.91$44.34M$0.08193.25GRAIL$134.29M8.69-$2.03B-$13.11-2.47 Which has more risk and volatility, SHC or GRAL? Sotera Health has a beta of 1.84, suggesting that its stock price is 84% more volatile than the S&P 500. Comparatively, GRAIL has a beta of 3.18, suggesting that its stock price is 218% more volatile than the S&P 500. Do analysts recommend SHC or GRAL? Sotera Health currently has a consensus price target of $16.00, indicating a potential upside of 3.49%. GRAIL has a consensus price target of $31.50, indicating a potential downside of 2.69%. Given Sotera Health's stronger consensus rating and higher possible upside, research analysts plainly believe Sotera Health is more favorable than GRAIL.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sotera Health 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80GRAIL 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 Does the media prefer SHC or GRAL? In the previous week, Sotera Health had 2 more articles in the media than GRAIL. MarketBeat recorded 11 mentions for Sotera Health and 9 mentions for GRAIL. Sotera Health's average media sentiment score of 1.41 beat GRAIL's score of 1.17 indicating that Sotera Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sotera Health 8 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GRAIL 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of SHC or GRAL? 91.0% of Sotera Health shares are held by institutional investors. 47.5% of Sotera Health shares are held by company insiders. Comparatively, 1.9% of GRAIL shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. SummarySotera Health beats GRAIL on 14 of the 16 factors compared between the two stocks. Get GRAIL News Delivered to You Automatically Sign up to receive the latest news and ratings for GRAL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GRAL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRAL vs. The Competition Export to ExcelMetricGRAILMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.16B$3.12B$5.77B$9.72BDividend YieldN/A2.28%6.66%4.49%P/E Ratio-2.4621.1082.6126.60Price / Sales8.69364.08504.06158.88Price / Cash1.1443.5325.7028.92Price / Book0.508.1310.876.56Net Income-$2.03B-$53.35M$3.28B$266.04M7 Day Performance-5.10%0.73%0.10%-0.89%1 Month Performance-2.59%7.76%8.93%4.34%1 Year Performance142.84%11.97%51.11%24.06% GRAIL Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRALGRAIL1.3354 of 5 stars$32.37-0.2%$31.50-2.7%+144.5%$1.16B$134.29M-2.461,360Positive NewsSHCSotera Health2.344 of 5 stars$16.39-0.2%$16.00-2.4%+4.0%$4.67B$1.10B204.903,000Positive NewsOPCHOption Care Health4.773 of 5 stars$28.06-2.4%$35.75+27.4%-10.6%$4.66B$5.37B22.458,088Positive NewsBTSGBrightSpring Health Services1.6725 of 5 stars$24.08-3.2%$25.67+6.6%+92.3%$4.41B$11.27B77.6835,000Positive NewsNAKAKindlyMD2.2602 of 5 stars$9.17-9.5%N/AN/A$3.81B$2.72M-10.66N/ANews CoverageAnalyst ForecastGap DownWGSGeneDx1.8766 of 5 stars$121.87-5.3%$101.63-16.6%+314.0%$3.70B$305.45M2,437.401,200CONConcentra Group Holdings Parent2.4057 of 5 stars$23.36-1.2%$27.50+17.7%-0.6%$3.03B$1.90B19.6311,250Positive NewsSGRYSurgery Partners3.3566 of 5 stars$23.04-2.5%$33.00+43.2%-28.4%$3.03B$3.11B-16.1115,000News CoveragePositive NewsPRVAPrivia Health Group3.983 of 5 stars$21.40-2.7%$28.00+30.8%+20.1%$2.70B$1.74B194.561,140Analyst RevisionVCYTVeracyte3.2013 of 5 stars$29.55-4.7%$40.90+38.4%+1.1%$2.44B$445.76M89.55790Positive NewsHTFLHeartflowN/A$29.84+2.3%N/AN/A$2.37BN/A0.00699News CoverageAnalyst Forecast Related Companies and Tools Related Companies Sotera Health Alternatives Option Care Health Alternatives BrightSpring Health Services Alternatives KindlyMD Alternatives GeneDx Alternatives Concentra Group Holdings Parent Alternatives Surgery Partners Alternatives Privia Health Group Alternatives Veracyte Alternatives Heartflow Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GRAL) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GRAIL, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GRAIL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GRAL Stock Alerts